You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

Drugs Containing Excipient (Inactive Ingredient) DEXTRAN 40

✉ Email this page to a colleague

« Back to Dashboard

Branded drugs containing DEXTRAN 40 excipient, and estimated key patent expiration / generic entry dates

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
ER Squibb & Sons LLC	ETOPOPHOS	etoposide phosphate	0015-3404	DEXTRAN 40
H2-Pharma LLC	ETOPOPHOS	etoposide phosphate	61269-410	DEXTRAN 40
Acacia Pharma Ltd	BYFAVO	remimazolam besylate	71390-011	DEXTRAN 40	2027-07-10
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Generic drugs containing DEXTRAN 40 excipient

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc	gemtuzumab ozogamicin	0008-4510	DEXTRAN 40
ER Squibb & Sons LLC	etoposide phosphate	0015-3404	DEXTRAN 40
Novartis Pharmaceuticals Corporation	tisagenlecleucel	0078-0846	DEXTRAN 40
H2-Pharma LLC	etoposide phosphate	61269-410	DEXTRAN 40
Acacia Pharma Ltd	remimazolam besylate	71390-011	DEXTRAN 40
>Company	>Ingredient	>NDC	>Excipient

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.